Find uplifting stories about heroes, innovations, and solutions
115 results for "melanoma"
After Emily Robertson-Miller died suddenly from melanoma that spread to her brain, her loved ones turned grief into action. The community rallied at Geraldton's 15th Melanoma March, raising thousands for research and awareness.
University of Texas researchers solved a decade-long puzzle about why melanoma treatments work better when gradually reduced rather than stopped and restarted. Their discovery could help over 112,000 Americans diagnosed with melanoma this year get more effective care with fewer side effects.
Scientists created a heat-activated patch that killed 97% of melanoma lesions in mice without damaging healthy skin. The experimental treatment could one day replace invasive surgery for early-stage skin cancer.
A man's life was saved by two coincidences: his brother-in-law pointing out a spot on his leg, then stumbling upon a mobile skin cancer screening days later. His story highlights why catching melanoma early makes all the difference.
After years of setbacks, a new treatment for advanced melanoma just won FDA approval, giving patients a powerful option when other therapies have failed. The drug could help thousands facing one of the deadliest forms of skin cancer.
Two Australian scientists transformed melanoma from a death sentence into a treatable disease, saving hundreds of lives each year. Their breakthrough immunotherapy approach now gives patients a 55% survival rate where there was once almost no hope.
After 12 years and multiple melanoma diagnoses, Joe Eastin faced his toughest challenge when the cancer spread to his bones. Cutting-edge immunotherapy shrank his tumor by 50% in just three months.
A groundbreaking cancer therapy now lets doctors turn advanced melanoma tumors into personalized healing machines. The FDA-approved TIL therapy harnesses immune cells from a patient's own tumor to fight back against the disease.
A personalized mRNA vaccine from Moderna and Merck has shown remarkable five-year results against aggressive skin cancer. The therapy nearly halves the risk of melanoma returning after surgery.
A personalized mRNA vaccine combined with immunotherapy reduced melanoma recurrence or death by nearly half over five years. The breakthrough treatment, developed by Merck and Moderna, teaches the immune system to recognize and attack cancer cells.
A personalized cancer vaccine combined with immunotherapy has kept nearly 70% of melanoma patients cancer-free five years after surgery. The breakthrough offers new hope for preventing one of the deadliest skin cancers from coming back.
A personalized mRNA vaccine combined with immunotherapy stopped melanoma from returning in 69% of patients over five years, nearly double the rate of standard treatment alone. The breakthrough could transform how doctors fight not just skin cancer, but many other cancers too.
A promising viral cancer therapy just cleared a major hurdle, giving new hope to advanced melanoma patients. After two rejections, an FDA expert panel voted 10-3 to recommend Replimune's innovative treatment for review.
Jenney was diagnosed with stage 4 metastatic melanoma, a cancer that once meant almost certain death. Thanks to immunotherapy, she had no evidence of disease after just five months of treatment.
A personalized mRNA vaccine combined with immunotherapy slashed skin cancer recurrence rates in over 1,000 high-risk melanoma patients. It's the first late-stage trial success for mRNA cancer treatment, opening new hope for patients worldwide.
After decades of careful sun protection, Sherry O'Daniell was devastated to learn childhood sun exposure had given her stage 3 melanoma. Thanks to new immunotherapy treatment, she's now cancer-free and sharing her story to help others.
A groundbreaking study shows personalized mRNA vaccines combined with immunotherapy kept nearly 70% of melanoma patients cancer-free after five years, compared to just 49% with immunotherapy alone. The same technology that powered COVID-19 vaccines is now transforming how we fight cancer.
Researchers discovered how melanoma cells bypass aging to become deadly, uncovering a hidden genetic partnership that keeps tumors dividing indefinitely. The breakthrough reveals a potential new target for future cancer treatments. #
Scientists at a Wisconsin VA hospital have discovered how to slow aggressive melanoma growth by targeting a specific protein, offering new hope for veterans facing one of the military's most common service-connected cancers.
Scientists at UC San Diego discovered that catestatin, a naturally occurring peptide in our bodies, can slow melanoma growth and overcome drug resistance. This breakthrough could transform how doctors treat one of the deadliest forms of skin cancer.
Showing 20 of 115